Melius MicroBiomics Inc.
The Gibson Lab created two genetically engineered microbial medicines (GEMM™), BioPersist™ & BioColonize™. Melius MicroBiomics Inc. has licensed this UBC IP to take these products to market. Dr. Deanna Gibson is the current Chief Scientific Officer (CSO) of Melius.
Visit our website here
Learn more about the story behind Melius and GEMM technology here.
